Username or Email Address
Gilead Sciences Inc does not need to acquire for GILD stock to reverse course and trade higher. Brian & Liam take two angles on Gilead stock.
ICPT jumped 6% after Intercept Pharmaceuticals issued an update on OCA in treating NASH. Is Intercept stock now a buy?
Gilead Sciences’ guidance was horrible, & GILD stock should be down 15%. There’s a good reason it only fell 5%, and why Gilead stock will recover.
A bidding war for Acadia Pharmaceuticals and Nuplazid is likely to ensue after buyout rumors last Friday. Great news for ACAD stock owners.
BNL analyst Eddy Parton called CARA stock back in November before a 60% gain. Eddy revisits Cara Therapeutics to determine whether to buy, sell, or hold.
SGYP stock fell nearly 15% after Synergy Pharmaceuticals announced a larger offering at a lower price than expected. However, that’s not the biggest concern
The Walgreens Rite Aid buyout terms have changed, and RAD stock owners must consider there is more to this story with WBA.
Address: 37 North OrangeAvenue Suite 500, Orlando,FL 32801.
Phone: (+1) (407) 488-1818